<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36921032</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1946-6242</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>687</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>15</Day></PubDate></JournalIssue><Title>Science translational medicine</Title><ISOAbbreviation>Sci Transl Med</ISOAbbreviation></Journal><ArticleTitle>Host-derived mannose glycans trigger a pathogenic &#x3b3;&#x3b4; T cell/IL-17a axis in autoimmunity.</ArticleTitle><Pagination><StartPage>eabo1930</StartPage><MedlinePgn>eabo1930</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1126/scitranslmed.abo1930</ELocationID><Abstract><AbstractText>Autoimmune diseases are life-threatening disorders that cause increasing disability over time. Systemic lupus erythematosus (SLE) and other autoimmune diseases arise when immune stimuli override mechanisms of self-tolerance. Accumulating evidence has demonstrated that protein glycosylation is substantially altered in autoimmune disease development, but the mechanisms by which glycans trigger these autoreactive immune responses are still largely unclear. In this study, we found that presence of microbial-associated mannose structures at the surface of the kidney triggers the recognition of DC-SIGN-expressing &#x3b3;&#x3b4; T cells, inducing a pathogenic interleukin-17a (IL-17a)-mediated autoimmune response. Mice lacking <i>Mgat5</i>, which have a higher abundance of mannose structures in the kidney, displayed increased &#x3b3;&#x3b4; T cell infiltration into the kidney that was associated with spontaneous development of lupus in older mice. <i>N</i>-acetylglucosamine supplementation, which promoted biosynthesis of tolerogenic branched N-glycans in the kidney, was found to inhibit &#x3b3;&#x3b4; T cell infiltration and control disease development. Together, this work reveals a mannose-&#x3b3;&#x3b4; T cell-IL-17a axis in SLE immunopathogenesis and highlights glycometabolic reprogramming as a therapeutic strategy for autoimmune disease treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alves</LastName><ForeName>In&#xea;s</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-3914-7101</Identifier><AffiliationInfo><Affiliation>i3s - Institute for Research and Innovation in Health, University of Porto, 4200-135 Porto, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos-Pereira</LastName><ForeName>Beatriz</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-7094-0394</Identifier><AffiliationInfo><Affiliation>i3s - Institute for Research and Innovation in Health, University of Porto, 4200-135 Porto, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de la Cruz</LastName><ForeName>Noelia</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-9917-1234</Identifier><AffiliationInfo><Affiliation>Glycosystems Laboratory, Instituto de Investigaciones Qu&#xed;micas (IIQ), CSIC - Universidad de Sevilla, 41092 Sevilla, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campar</LastName><ForeName>Ana</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3951-8961</Identifier><AffiliationInfo><Affiliation>i3s - Institute for Research and Innovation in Health, University of Porto, 4200-135 Porto, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ICBAS-School of Medicine and Biomedical Sciences, University of Porto, 4050-313 Porto, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Immunology, Centro Hospitalar Universit&#xe1;rio do Porto, 4099-001 Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinto</LastName><ForeName>Vanda</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-9979-1663</Identifier><AffiliationInfo><Affiliation>i3s - Institute for Research and Innovation in Health, University of Porto, 4200-135 Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodrigues</LastName><ForeName>Pedro M</ForeName><Initials>PM</Initials><Identifier Source="ORCID">0000-0002-3256-5060</Identifier><AffiliationInfo><Affiliation>i3s - Institute for Research and Innovation in Health, University of Porto, 4200-135 Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ara&#xfa;jo</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3997-6209</Identifier><AffiliationInfo><Affiliation>i3s - Institute for Research and Innovation in Health, University of Porto, 4200-135 Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>Sofia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-1521-0724</Identifier><AffiliationInfo><Affiliation>Nephrology Department, Centro Hospitalar e Universit&#xe1;rio do Porto, 4099-001 Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramos-Soriano</LastName><ForeName>Javier</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3054-0679</Identifier><AffiliationInfo><Affiliation>Glycosystems Laboratory, Instituto de Investigaciones Qu&#xed;micas (IIQ), CSIC - Universidad de Sevilla, 41092 Sevilla, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasconcelos</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-8073-5028</Identifier><AffiliationInfo><Affiliation>ICBAS-School of Medicine and Biomedical Sciences, University of Porto, 4050-313 Porto, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Immunology, Centro Hospitalar Universit&#xe1;rio do Porto, 4099-001 Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-0233-973X</Identifier><AffiliationInfo><Affiliation>Department of Pathology, Hospital Universit&#xe1;rio S&#xe3;o Jo&#xe3;o do Porto, 4200-319 Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Afonso</LastName><ForeName>Nuno</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Centro Hospitalar Universit&#xe1;rio de Coimbra, 3004-561 Coimbra, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mira</LastName><ForeName>Filipe</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-5682-3116</Identifier><AffiliationInfo><Affiliation>Department of Nephrology, Centro Hospitalar Universit&#xe1;rio de Coimbra, 3004-561 Coimbra, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barrias</LastName><ForeName>Cristina C</ForeName><Initials>CC</Initials><Identifier Source="ORCID">0000-0002-8178-6134</Identifier><AffiliationInfo><Affiliation>i3s - Institute for Research and Innovation in Health, University of Porto, 4200-135 Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alves</LastName><ForeName>Nuno L</ForeName><Initials>NL</Initials><Identifier Source="ORCID">0000-0002-1567-8389</Identifier><AffiliationInfo><Affiliation>i3s - Institute for Research and Innovation in Health, University of Porto, 4200-135 Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rojo</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Glycosystems Laboratory, Instituto de Investigaciones Qu&#xed;micas (IIQ), CSIC - Universidad de Sevilla, 41092 Sevilla, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>L&#xe9;lita</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-0761-5097</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Centro Hospitalar Universit&#xe1;rio de Coimbra, 3004-561 Coimbra, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marinho</LastName><ForeName>Ant&#xf3;nio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3295-6723</Identifier><AffiliationInfo><Affiliation>ICBAS-School of Medicine and Biomedical Sciences, University of Porto, 4050-313 Porto, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Immunology, Centro Hospitalar Universit&#xe1;rio do Porto, 4099-001 Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinho</LastName><ForeName>Salom&#xe9; S</ForeName><Initials>SS</Initials><Identifier Source="ORCID">0000-0002-3484-5162</Identifier><AffiliationInfo><Affiliation>i3s - Institute for Research and Innovation in Health, University of Porto, 4200-135 Porto, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ICBAS-School of Medicine and Biomedical Sciences, University of Porto, 4050-313 Porto, Portugal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sci Transl Med</MedlineTA><NlmUniqueID>101505086</NlmUniqueID><ISSNLinking>1946-6234</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>PHA4727WTP</RegistryNumber><NameOfSubstance UI="D008358">Mannose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020381">Interleukin-17</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016692">Receptors, Antigen, T-Cell, gamma-delta</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Rheumatol. 2023 May;19(5):258</RefSource><PMID Version="1">37012359</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Nephrol. 2023 Jun;19(6):359</RefSource><PMID Version="1">37130927</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015551" MajorTopicYN="N">Autoimmunity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008358" MajorTopicYN="N">Mannose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020381" MajorTopicYN="N">Interleukin-17</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016692" MajorTopicYN="N">Receptors, Antigen, T-Cell, gamma-delta</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>15</Day><Hour>14</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36921032</ArticleId><ArticleId IdType="doi">10.1126/scitranslmed.abo1930</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>